Scarica l'app Stockscreener
14.94
0.60%
-0.09
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché RDY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Dr Reddys Laboratories Ltd Adr Borsa (RDY) Ultime notizie
Asian ADRs Climb With North And South Leaders - Finimize
Dr Reddys Laboratories allots Equity shares - Business Standard
RDY’s Market Whiplash: 2.41% YTD Rise, 14.68% Rise in 30 Days - investchronicle.com
Stocks Showing Rising Market Leadership: Dr. Reddy's Labs ADR Earns 81 RS Rating - Investor's Business Daily
Yatsen And Zai Lab Shine As Asian ADRs Climb In The US - Finimize
HSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from Hold - Insider Monkey
Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech By Investing.com - Investing.com Nigeria
Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech - Investing.com Australia
HSBC upgrades Dr. Reddy’s stock rating citing semaglutide prospects - Investing.com
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab) - GlobeNewswire Inc.
LLY Stock Quote Price and Forecast - CNN
Asian Equities Gain In US Markets' Positive Start - Finimize
Dr. Reddy’s Laboratories Receives USFDA Observations After Recent Inspection - TipRanks
Dr Reddys Laboratories shares climb over 1.1% amid increased trading volume in today's session - Moneycontrol
Axa S.A. Has $1.23 Million Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Indian ADRs Surge in US Markets as Wall Street soars after US-China trade talks - Moneycontrol
Shares To Buy For Short-term: Analysts recommend 5 largecap, 2 midcap stocks; Britannia, Dr Reddy's, TCS on the list - Zee Business
Wells Fargo & Company MN Has $124,000 Holdings in Dr. Reddy’s Laboratories Limited (NYSE:RDY) - Defense World
Asian Equities Climb Despite Weekly Losses - Finimize
Dr. Reddy’s Earnings: Year-End Numbers Look Solid as Demand and Prescription Trends Remain Resilient - Morningstar
Dr. Reddy’s Laboratories Grants Stock Options to Employees in May 2025 - TipRanks
Insider’s View: Deciphering Six Flags Entertainment Corp (FUN)’s Financial Health Through Ratios - DWinneX
Balance Sheet Breakdown: Astrazeneca plc ADR (AZN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Ratio Examination: Dr. Reddy’s Laboratories Ltd. ADR (RDY)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Metric Deep Dive: Understanding Phio Pharmaceuticals Corp (PHIO) Through its Ratios - DWinneX
Financial Analysis: Spotify Technology S.A (SPOT)’s Ratios Unveil Key Insights - DWinneX
5 Indian ADRs crash up to 14% amid rising India-Pakistan military conflict - Trade Brains
Q4 Results Highlights: Dr. Reddy's Laboratories profit rises 22% YoY to ₹1,594 crore, dividend recommended - Upstox
Indian Markets Set for Bloody Friday as Gift Nifty Signals Sharp Gap-Down Open Amid Escalating India-Pak Tensions - outlookbusiness.com
Indian ADRs slump as India-Pakistan conflict sees escalation - Moneycontrol
Gift Nifty, India ADRs see sharp sell-off following escalation in India-Pakistan conflict - Moneycontrol
Dr. Reddy’s Labs Q4 FY25 Results Preview: Revenue & PAT Outlook - Samco
Validea's Top Health Care Stocks Based On Peter Lynch5/5/2025 - Nasdaq
Nomura’s top pharma bets include Dr. Reddy’s, Cipla, Lupin and Zydus - financialexpress.com
Asian ADRs See Mixed Results Despite Weekly Gains - Finimize
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Dr. Reddy’s Looks Well Positioned for Long-Term Growth, Aided by Acquisitions and Partnerships - Morningstar
Investing in Dr. Reddy’s Laboratories Ltd. ADR (RDY): What You Must Know - knoxdaily.com
Dr Reddys Share Price Highlights: Dr. Reddys Stock Price History - The Economic Times
NVO Stock Quote Price and Forecast - CNN
Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com
Asian ADRs Climb, Showcasing North And South Asia Performances - Finimize
Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals - Yahoo Finance
PDD Holdings Stock Delivers Phenomenal 5.82% Surge to $95.77 on April 14 – Bullish Momentum Lifts Chinese Tech - Hindustan Herald
3 Generic Drug Stocks To Watch Amid Trade War Jitters & Inflation Woes - Barchart.com
Dr Reddy’s may cut workforce by 25%, including those in Rs 1 crore bracket: Report - financialexpress.com
1.24%
0.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):